Does cytogenetic mosaicism in CD34+CD38low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis? [4]

Blood

Volumn 102, Issue 4, 2003, Pages 1551-1552

  Bilhou Nabéra, Chrystèle ^a   Brigaudeau, Christophe ^b   Clay, Denis ^b   Andrieux, Joris ^b   Lai, Jean Luc ^b   Brouty Boyé, Danielle ^b   Vignon, Christine ^b   Gharbi, Marie Josée ^b   Le Bousse Kerdilès, Marie Caroline ^b   Praloran, Vincent ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; BLOOD ANALYSIS; CHROMOSOME DELETION; CHROMOSOME MOSAICISM; CHROMOSOME TRANSLOCATION; CLONAL VARIATION; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; KARYOTYPE; LETTER; LEUKOCYTE; METAPHASE; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE;

EID: 17344394471     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-03-0691     Document Type: Letter

References (8)

1. Barosi G. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol. 17:2954-2970, 1999
2. Dupriez B, Morel P, Demory JL, Lai JL, Simon M, Plantier I, Bauters F. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood. 1996;88:136-137.
3. Le Bousse-Kerdilès MC, Martyrè MC. Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia: French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia. Springer Sem Immunopathol. 2000;21:491-508.
4. Le Bousse-Kerdilès MC, Chevillard S, Charpentier A, et al. Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood. 1996;88:4534-4546.
5. Brigaudeau C, Gachard N, Clay D, Fixe P, Rouzier E, Praloran V. A "miniaturized" method for the karyotypic analysis of bone marrow or blood samples in hematological malignancies. Hematol Cell Ther. 1996;38:275-277.
6. Tefferi A, Mesa RA, Schroeder G, Hanson CA, Li CY, Dewald GW. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia. Brit J Haematol. 2001;113:763-771.
7. Mitelman F. ISCN (1995): an International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger; 1995.
8. Reeder TL, Bailey RJ, Dewald G, Tefferi A. Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia. Blood. 2003;101:1981-1983.